D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 56 Citations 10,162 175 World Ranking 10011 National Ranking 739

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Enzyme

His primary scientific interests are in Integrin, Lymphocyte function-associated antigen 1, Biophysics, Cell adhesion and Stereochemistry. Motomu Shimaoka interconnects Ligand, Binding domain, Transmembrane domain, Intercellular Adhesion Molecule-1 and Conformational change in the investigation of issues within Integrin. His biological study spans a wide range of topics, including Small interfering RNA, Molecular biology, RNA interference, Lymphocyte and Gene silencing.

His Biophysics study incorporates themes from Allosteric regulation and Small molecule. His Cell adhesion research includes elements of Plasma protein binding, Signal transduction, G protein and Cell biology. His Stereochemistry study typically links adjacent topics like Protein structure.

His most cited work include:

  • Conformational Regulation of Integrin Structure and Function (462 citations)
  • Structures of the αL I Domain and Its Complex with ICAM-1 Reveal a Shape-Shifting Pathway for Integrin Regulation (443 citations)
  • Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. (437 citations)

What are the main themes of his work throughout his whole career to date?

Motomu Shimaoka focuses on Integrin, Cell biology, Cell adhesion, Immunology and Lymphocyte function-associated antigen 1. The study incorporates disciplines such as Ligand, Biophysics, Stereochemistry, Cell adhesion molecule and Allosteric regulation in addition to Integrin. Motomu Shimaoka has researched Stereochemistry in several fields, including Protein structure, Binding domain and Alpha.

His Cell biology research also works with subjects such as

  • RNA interference which is related to area like Gene silencing, Small interfering RNA and Gene knockdown,
  • Cell migration that intertwine with fields like Motility. His Cell adhesion study combines topics in areas such as Intercellular Adhesion Molecule-1, In vitro and Molecular biology. As a member of one scientific family, Motomu Shimaoka mostly works in the field of Lymphocyte function-associated antigen 1, focusing on Binding site and, on occasion, Isoflurane.

He most often published in these fields:

  • Integrin (45.00%)
  • Cell biology (35.56%)
  • Cell adhesion (16.67%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cell biology (35.56%)
  • Integrin (45.00%)
  • Inflammation (14.44%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Cell biology, Integrin, Inflammation, Microvesicles and Cell adhesion. His research in the fields of Homing, Crosstalk and Connexin overlaps with other disciplines such as Thrombomodulin. His Integrin study improves the overall literature in Receptor.

His Inflammation research is multidisciplinary, relying on both Myokine, Immune system and Sepsis. Motomu Shimaoka focuses mostly in the field of Microvesicles, narrowing it down to matters related to Endosome and, in some cases, Pannexin and Actin. As part of one scientific family, Motomu Shimaoka deals mainly with the area of Cell adhesion, narrowing it down to issues related to the Extracellular matrix, and often Flow cytometry, Ligand and Cell membrane.

Between 2018 and 2021, his most popular works were:

  • Connexins and Integrins in Exosomes. (27 citations)
  • Exosomal regulation of lymphocyte homing to the gut (23 citations)
  • Integrin and PD-1 Ligand Expression on Circulating Extracellular Vesicles in Systemic Inflammatory Response Syndrome and Sepsis. (17 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Enzyme

Motomu Shimaoka mainly investigates Cell biology, Integrin, Microvesicles, Inflammation and Sepsis. His Cell biology research includes themes of Cancer cell, Cell morphology and Tube formation. His research in Integrin intersects with topics in Renal function, Central nervous system, Transmembrane protein, Systemic inflammatory response syndrome and Cell adhesion.

His Microvesicles research focuses on subjects like Homing, which are linked to Chemokine, Cell adhesion molecule and Immune system. His Inflammation research is multidisciplinary, incorporating elements of Extracellular, Serine, Peripheral blood mononuclear cell and Recombinant DNA. The Sepsis study combines topics in areas such as Lung injury, Receptor expression and Type 2 immune response.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Conformational Regulation of Integrin Structure and Function

Motomu Shimaoka;Junichi Takagi;Timothy A Springer.
Annual Review of Biophysics and Biomolecular Structure (2002)

654 Citations

Structures of the αL I Domain and Its Complex with ICAM-1 Reveal a Shape-Shifting Pathway for Integrin Regulation

Motomu Shimaoka;Tsan Sam Xiao;Jin Huan Liu;Yuting Yang.
Cell (2003)

608 Citations

Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target.

Dan Peer;Eun Jeong Park;Yoshiyuki Morishita;Christopher V. Carman.
Science (2008)

519 Citations

Therapeutic antagonists and conformational regulation of integrin function

Motomu Shimaoka;Timothy A. Springer.
Nature Reviews Drug Discovery (2003)

422 Citations

Activation of Leukocyte β2 Integrins by Conversion from Bent to Extended Conformations

Noritaka Nishida;Can Xie;Motomu Shimaoka;Yifan Cheng.
Immunity (2006)

293 Citations

Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1

Dan Peer;Pengcheng Zhu;Christopher V. Carman;Judy Lieberman.
Proceedings of the National Academy of Sciences of the United States of America (2007)

293 Citations

Reversibly locking a protein fold in an active conformation with a disulfide bond: Integrin αL I domains with high affinity and antagonist activity in vivo

Motomu Shimaoka;Chafen Lu;Roger T. Palframan;Ulrich H. von Andrian.
Proceedings of the National Academy of Sciences of the United States of America (2001)

286 Citations

Identification of the target self-antigens in reperfusion injury

Ming Zhang;Elisabeth M. Alicot;Isaac Chiu;Jinan Li.
Journal of Experimental Medicine (2006)

252 Citations

Rolling Adhesion through an Extended Conformation of Integrin αLβ2 and Relation to α I and β I-like Domain Interaction

Azucena Salas;Motomu Shimaoka;Avi N Kogan;Charlotte Harwood.
Immunity (2004)

244 Citations

Ventilator-Induced Lung Injury Is Associated with Neutrophil Infiltration, Macrophage Activation, and TGF-β1 mRNA Upregulation in Rat Lungs

Hideaki Imanaka;Motomu Shimaoka;Nariaki Matsuura;Masaji Nishimura.
Anesthesia & Analgesia (2001)

243 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Motomu Shimaoka

Timothy A. Springer

Timothy A. Springer

Boston Children's Hospital

Publications: 82

Ronen Alon

Ronen Alon

Weizmann Institute of Science

Publications: 29

Klaus Ley

Klaus Ley

La Jolla Institute For Allergy & Immunology

Publications: 27

Mark H. Ginsberg

Mark H. Ginsberg

University of California, San Diego

Publications: 27

Alexander Zarbock

Alexander Zarbock

University of Münster

Publications: 27

Cheng Zhu

Cheng Zhu

Georgia Institute of Technology

Publications: 26

Martin J. Humphries

Martin J. Humphries

University of Manchester

Publications: 22

Michael L. Dustin

Michael L. Dustin

University of Oxford

Publications: 19

Scott I. Simon

Scott I. Simon

University of California, Davis

Publications: 18

John J. Rossi

John J. Rossi

City Of Hope National Medical Center

Publications: 17

Carl G. Gahmberg

Carl G. Gahmberg

University of Helsinki

Publications: 17

Nancy Hogg

Nancy Hogg

Cancer Research UK London Research Institute

Publications: 17

Jyrki Heino

Jyrki Heino

University of Turku

Publications: 16

David J. Ecker

David J. Ecker

Ionis Pharmaceuticals (United States)

Publications: 16

Junichi Takagi

Junichi Takagi

Osaka University

Publications: 16

Larry A. Sklar

Larry A. Sklar

University of New Mexico

Publications: 15

Trending Scientists

James R. Curran

James R. Curran

University of Sydney

Byonghyo Shim

Byonghyo Shim

Seoul National University

Subhabrata Sen

Subhabrata Sen

AT&T (United States)

Kimberly Keeton

Kimberly Keeton

Hewlett-Packard (United States)

Jeffrey Rogers

Jeffrey Rogers

Baylor College of Medicine

Debra P. C. Peters

Debra P. C. Peters

United States Department of Agriculture

Gary L. Schieven

Gary L. Schieven

Genesis Biotechnology Group

Jana Seifert

Jana Seifert

University of Hohenheim

Qiang Zhou

Qiang Zhou

University of California, Berkeley

Maoyan Zhu

Maoyan Zhu

Chinese Academy of Sciences

Marco Capogna

Marco Capogna

Aarhus University

Wenjun Ouyang

Wenjun Ouyang

Amgen (United States)

Michael P. Twohig

Michael P. Twohig

Utah State University

John P. Klein

John P. Klein

Medical College of Wisconsin

Dennis Velakoulis

Dennis Velakoulis

University of Melbourne

Brenda A. Miller

Brenda A. Miller

Pacific Institute For Research and Evaluation

Something went wrong. Please try again later.